Account
Insider Insights
01.02.2022
NICEs new methods and processes manual

The National Institute for Health and Care Excellence (NICE) on 31st January 2022 published its new ...

Read more
Articles
25.01.2022
PMA Perspectives Q1 2022

We hope you’ve had a wonderful start to the New Year and we’d love to welcome you to our fourth ...

Read more
News
15.12.2021
PMA Insights: Week 51 2021

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more
Articles
07.12.2021
What are the 5 Pricing & Market Access trends ...

Our experts provide an overview of the five key trends that could shape the pricing and market acces...

Read more
Publications
03.12.2021
Highly specialised technologies process

Is the National Institute for Health and Care Excellence (NICE) becoming more efficient in evaluatin...

Read more
Publications
03.12.2021
Orphan drug status benefit

The purpose of this study is to compare the assessments of orphan and non-orphan drugs by NICE.

Read more
News
27.11.2021
PMA Insights: Week 43

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more
News
24.11.2021
PMA Insights: Week 47 2021

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more
Articles
22.11.2021
NICE cost effective medicines

When making a decision about the approval of a new product NICE (National Institute for Health and C...

Read more
News
10.11.2021
PMA Insights: Week 45

We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.